Biostar Pharmaceuticals BSPM Stock
Biostar Pharmaceuticals Price Chart
Biostar Pharmaceuticals BSPM Financial and Trading Overview
Biostar Pharmaceuticals stock price | 0.0001 USD |
Previous Close | 1.0E-6 USD |
Open | 1.0E-6 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 1.0E-6 - 1.0E-6 USD |
52 Week Range | 1.0E-6 - 0.01 USD |
Volume | 2 USD |
Avg. Volume | 0 USD |
Market Cap | 31 USD |
Beta (5Y Monthly) | -3022.4402 |
PE Ratio (TTM) | 1.6666667E-5 |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BSPM Valuation Measures
Enterprise Value | 2.06M USD |
Trailing P/E | 1.6666667E-5 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 9.754747E-5 |
Price/Book (mrq) | 7.295542E-8 |
Enterprise Value/Revenue | 6.489 |
Enterprise Value/EBITDA | 0.53 |
Trading Information
Biostar Pharmaceuticals Stock Price History
Beta (5Y Monthly) | -3022.4402 |
52-Week Change | 9900.00% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.01 USD |
52 Week Low | 1.0E-6 USD |
50-Day Moving Average | 0.01 USD |
200-Day Moving Average | 0.01 USD |
BSPM Share Statistics
Avg. Volume (3 month) | 0 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 2.64M |
Float | 2.21M |
Short Ratio | 3 |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | 170.44K |
Short % of Float | N/A |
Short % of Shares Outstanding | 6.46% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:7 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2016 |
Most Recent Quarter (mrq) | September 30, 2017 |
Next Fiscal Year End | December 31, 2017 |
Profitability
Profit Margin | 294.01% |
Operating Margin (ttm) | 876.46% |
Gross Margin | -11.56% |
EBITDA Margin | 1225.42% |
Management Effectiveness
Return on Assets (ttm) | 4.24% |
Return on Equity (ttm) | 2.66% |
Income Statement
Revenue (ttm) | 317.79K USD |
Revenue Per Share (ttm) | 0.12 USD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | 915.17K USD |
EBITDA | 3.89M USD |
Net Income Avi to Common (ttm) | 934.35K USD |
Diluted EPS (ttm) | 0.06 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 364.97K USD |
Total Cash Per Share (mrq) | 0.14 USD |
Total Debt (mrq) | 2.43M USD |
Total Debt/Equity (mrq) | 6.71 USD |
Current Ratio (mrq) | 0.189 |
Book Value Per Share (mrq) | 13.707 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.59M USD |
Levered Free Cash Flow (ttm) | 7.47M USD |
Profile of Biostar Pharmaceuticals
Country | United States |
State | N/A |
City | Xianyang |
Address | No. 588 Shiji Xi Road |
ZIP | 712000 |
Phone | 86 29 3368 6638 |
Website | https://biostarpharmaceuticals.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 200 |
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Q&A For Biostar Pharmaceuticals Stock
What is a current BSPM stock price?
Biostar Pharmaceuticals BSPM stock price today per share is 0.0001 USD.
How to purchase Biostar Pharmaceuticals stock?
You can buy BSPM shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biostar Pharmaceuticals?
The stock symbol or ticker of Biostar Pharmaceuticals is BSPM.
Which industry does the Biostar Pharmaceuticals company belong to?
The Biostar Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Biostar Pharmaceuticals have in circulation?
The max supply of Biostar Pharmaceuticals shares is 3.16B.
What is Biostar Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Biostar Pharmaceuticals PE Ratio is now.
What was Biostar Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Biostar Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Biostar Pharmaceuticals company belong to?
The Biostar Pharmaceuticals sector is Healthcare.
Biostar Pharmaceuticals BSPM included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite Total Return I XCMP | 20257.83 USD — |
-5.96
|
— — | 20236.33 USD — | 20672.41 USD — | — - | — — |
- {{ link.label }} {{link}}